Based on the RHÖN-KLINIKUM Aktiengesellschaft stock forecast from 0 analysts, the average analyst target price for RHÖN-KLINIKUM Aktiengesellschaft is not available over the next 12 months. RHÖN-KLINIKUM Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of RHÖN-KLINIKUM Aktiengesellschaft is Bullish , which is based on 7 positive signals and 3 negative signals. At the last closing, RHÖN-KLINIKUM Aktiengesellschaft’s stock price was EUR 10.90. RHÖN-KLINIKUM Aktiengesellschaft’s stock price has changed by -4.39% over the past week, -1.80% over the past month and -16.15% over the last year.
No recent analyst target price found for RHÖN-KLINIKUM Aktiengesellschaft
No recent average analyst rating found for RHÖN-KLINIKUM Aktiengesellschaft
Company Overview RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany. Read Less
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry,...Read More
Frequently Asked Questions About RHÖN-KLINIKUM Aktiengesellschaft (RHK:XETRA) Stock
Stock Target Advisor's fundamental analysis for RHÖN-KLINIKUM Aktiengesellschaft's stock is Bullish .
RHK:XETRA stock's dividend yield is 1.36%.
Our analysis grades RHK:XETRA stock's dividend yield at F. This means that RHK:XETRA stock's dividend yield is above 33% of the stocks in the Medical Care Facilities sector in the XETRA exchange.
Based on this RHK:XETRA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on RHK:XETRA's stock to indicate what its average analyst target is.
RHK:XETRA stock's Price/Earning ratio is 23.88.
Our analysis grades RHK:XETRA stock's Price / Earning ratio at C-. This means that RHK:XETRA stock's Price/Earning ratio is above 29% of the stocks in the Medical Care Facilities sector in the XETRA exchange.
Based on this RHK:XETRA may be undervalued for its sector.
The last closing price of RHK:XETRA's stock was EUR 10.90.
The most recent market capitalization for RHK:XETRA is EUR 0.78B.
Unfortunately we do not have enough analyst data on RHK:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains RHÖN-KLINIKUM Aktiengesellschaft's stock.
As per our most recent records RHÖN-KLINIKUM Aktiengesellschaft has 18,158 Employees.
RHÖN-KLINIKUM Aktiengesellschaft's registered address is Salzburger Leite 1, Bad Neustadt an der Saale, Germany, 97616.
You can get more information about it from RHÖN-KLINIKUM Aktiengesellschaft's website at https://www.rhoen-klinikum-ag.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RHK:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
